| Date Filed | Type | Description |
| 07/26/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/06/2023 |
4
| GROSSMAN D KEITH (Executive Chairman) has filed a Form 4 on NEVRO CORP|
Txns:
| Paid exercise price by delivering 2,193 shares
@ $28.27, valued at
$62k
|
|
| 05/31/2023 |
4
| GROSSMAN D KEITH (Director) has filed a Form 4 on Outset Medical, Inc.|
Txns:
| Granted 7,681 shares
@ $0 |
|
| 04/26/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/13/2023 |
4
| GROSSMAN D KEITH (Chairman, President & CEO) has filed a Form 4 on NEVRO CORP|
Txns:
| Paid exercise price by delivering 4,263 shares
@ $35.66, valued at
$152k
|
|
| 03/14/2023 |
4
| GROSSMAN D KEITH (Chairman, President & CEO) has filed a Form 4 on NEVRO CORP|
Txns:
| Paid exercise price by delivering 2,757 shares
@ $30.19, valued at
$83.2k
|
|
| 03/07/2023 |
4
| GROSSMAN D KEITH (Chairman, President & CEO) has filed a Form 4 on NEVRO CORP|
Txns:
| Paid exercise price by delivering 8,798 shares
@ $34.43, valued at
$302.9k
|
|
| 06/01/2022 |
4
| GROSSMAN D KEITH (Director) has filed a Form 4 on Outset Medical, Inc.|
Txns:
| Granted 6,880 shares
@ $0 |
|
| 04/12/2022 |
4
| GROSSMAN D KEITH (Chairman, President & CEO) has filed a Form 4 on NEVRO CORP|
Txns:
| Paid exercise price by delivering 4,263 shares
@ $0 |
|
| 03/28/2022 |
4
| GROSSMAN D KEITH (Chairman, President & CEO) has filed a Form 4 on NEVRO CORP|
Txns:
| Granted 147,644 shares
@ $0
Paid exercise price by delivering 77,734 shares
@ $67.08, valued at
$5.2M
|
|
| 03/21/2022 |
4
| GROSSMAN D KEITH (Chairman, President & CEO) has filed a Form 4 on NEVRO CORP|
Txns:
| Paid exercise price by delivering 4,875 shares
@ $70.61, valued at
$344.2k
|
|
| 03/15/2022 |
4
| GROSSMAN D KEITH (Chairman, President & CEO) has filed a Form 4 on NEVRO CORP|
Txns:
| Paid exercise price by delivering 2,754 shares
@ $64.09, valued at
$176.5k
|
|
| 03/08/2022 |
4
| GROSSMAN D KEITH (Chairman, President & CEO) has filed a Form 4 on NEVRO CORP|
Txns:
| Bought 3,200 shares
@ $63.59, valued at
$203.5k
|
|
| 03/08/2022 |
4/A
| GROSSMAN D KEITH (Chairman, President & CEO) has filed a Form 4 on NEVRO CORP|
Txns:
| Granted 50,000 shares
@ $0 |
|
| 03/07/2022 |
4
| GROSSMAN D KEITH (Chairman, President & CEO) has filed a Form 4 on NEVRO CORP|
Txns:
| Granted 50,000 shares
@ $0
Granted 250,000 options to buy
@ $0 |
|
| 12/21/2021 |
4
| GROSSMAN D KEITH (Chairman, President & CEO) has filed a Form 4 on NEVRO CORP|
Txns:
| Paid exercise price by delivering 4,874 shares
@ $85.81, valued at
$418.2k
|
|
| 12/02/2021 |
4
| GROSSMAN D KEITH (Director) has filed a Form 4 on Outset Medical, Inc.|
Txns:
| Sold 1,296 shares
@ $47.92, valued at
$62.1k
|
|
| 11/02/2021 |
4
| GROSSMAN D KEITH (Director) has filed a Form 4 on Outset Medical, Inc.|
Txns:
| Sold 2,592 shares
@ $55, valued at
$142.6k
Sold 1,296 shares
@ $54.31, valued at
$70.4k
|
|
| 10/04/2021 |
4
| GROSSMAN D KEITH (Director) has filed a Form 4 on Outset Medical, Inc.|
Txns:
| Sold 62 shares
@ $49.69, valued at
$3.1k
Sold 1,234 shares
@ $49.69, valued at
$61.3k
Exercised 62 options to buy
@ $1.11, valued at
$68.8 |
|
| 10/04/2021 |
4
| GROSSMAN D KEITH (Director) has filed a Form 4 on Outset Medical, Inc.|
Txns:
| Sold 1,296 shares
@ $55, valued at
$71.3k
Exercised 1,296 options to buy
@ $1.11, valued at
$1.4k
|
|
| 09/21/2021 |
4
| GROSSMAN D KEITH (Chairman, President & CEO) has filed a Form 4 on NEVRO CORP|
Txns:
| Paid exercise price by delivering 4,874 shares
@ $126.63, valued at
$617.2k
|
|
| 09/01/2021 |
4
| GROSSMAN D KEITH (Director) has filed a Form 4 on Outset Medical, Inc.|
Txns:
| Sold 1,296 shares
@ $49.1675, valued at
$63.7k
Exercised 1,296 options to buy
@ $1.11, valued at
$1.4k
|
|
| 08/27/2021 |
4
| GROSSMAN D KEITH (Director) has filed a Form 4 on Outset Medical, Inc.|
Txns:
| Sold 1,296 shares
@ $45, valued at
$58.3k
Exercised 1,296 options to buy
@ $1.11, valued at
$1.4k
|
|
| 08/17/2021 |
4
| GROSSMAN D KEITH (Chairman, President & CEO) has filed a Form 4 on NEVRO CORP|
Txns:
| Bought 7,000 shares
@ $105.07, valued at
$735.5k
|
|
| 07/02/2021 |
4
| GROSSMAN D KEITH (Director) has filed a Form 4 on Outset Medical, Inc.|
Txns:
| Sold 1,296 shares
@ $49.2317, valued at
$63.8k
Exercised 1,296 options to buy
@ $1.11, valued at
$1.4k
|
|
| 06/22/2021 |
4
| GROSSMAN D KEITH (Chairman, President & CEO) has filed a Form 4 on NEVRO CORP|
Txns:
| Paid exercise price by delivering 4,874 shares
@ $160.45, valued at
$782k
|
|
| 06/04/2021 |
4
| GROSSMAN D KEITH (Director) has filed a Form 4 on Outset Medical, Inc.|
Txns:
| Granted 3,288 shares
@ $0 |
|
| 06/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/13/2021 |
4
| GROSSMAN D KEITH (Chairman, President & CEO) has filed a Form 4 on NEVRO CORP|
Txns:
| Paid exercise price by delivering 4,263 shares
@ $147.08, valued at
$627k
|
|
| 04/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/23/2021 |
4
| GROSSMAN D KEITH (Chairman, President & CEO) has filed a Form 4 on NEVRO CORP|
Txns:
| Paid exercise price by delivering 4,873 shares
@ $142.81, valued at
$695.9k
|
|
| 03/15/2021 |
4
| GROSSMAN D KEITH (Chairman, President & CEO) has filed a Form 4 on NEVRO CORP|
Txns:
| Granted 20,953 shares
@ $0 |
|
| 01/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|